AT&S (ATS.VI) — 2027Q1 FY2027 Earnings Call Analysis

Growth 40%, Every Plant Full, Cash Mix Withheld

Management says it could fill an extra co-packaged optics plant today, then says that product line contributes nothing this fiscal year.

Thesis: AT&S owns scarce substrate and co-packaged optics capacity. Pricing power is proven, utilization and ASP improvement are the largest earnings contributors, and Microelectronics is running +93% at 42% EBITDA margin. Guidance is backstopped by customer agreements running through FY2028-29 with prepayments and reservation fees, but the CFO refuses to split cash from contracted volume, so earnings quality is unverifiable. Near-term asymmetry favors the long; the EUR 1.5-2B Kulim 2 EMIB-T bet is the back-ended risk.

Verdict: LONG — Conviction: MEDIUM

Catalyst: Q2 landing fully inside the 45-55% growth range confirms the pricing unwind and Chongqing ramp, with co-packaged optics capacity expansion moving from plan to revenue in the next and over-next fiscal years.

Key Risk: Kulim 2 commits EUR 1.5-2B to EMIB-T against incumbent CoWoS with longevity called unknown by an analyst, while CapEx runs 1:1 to revenue. If hyperscaler substrate demand normalizes in 2028, growth capex becomes a margin drag.

The Tell: The CEO volunteered that global CPO demand is 'significantly bigger than it can be globally delivered' and that an extra plant could be filled today, then added it 'will not have an impact for this fiscal year.' He quantified a bottleneck with no revenue attached to it this year.

Detected Patterns

Beat and Raise Machine: Revenue +40% cc, EBITDA above 30%, EPS EUR 0.93, and management reconfirmed the upgraded 45-55% growth and 32-37% EBITDA guide with Q2 already inside range and no change to assessment.
Pricing Power Signal: Higher utilization is the largest earnings contributor with pricing improvement second, and CPO runs 5-10 points above baseline margin while management states demand exceeds global deliverable supply.
Backlog Fortress: Customer agreements include prepayments, capacity reservation fees and milestone bonuses spanning FY2028-29, built on management's zero negative cash flow business case model.
Capacity Ceiling: Management repeatedly says plants are full, last white spaces being filled in Chongqing, and no incremental CPO plant available this fiscal year. Full utilization caps the guide regardless of demand.
Backlog Quality: CFO declined to separate prepayment and capacity reservation components from contracted volume in the guide, so the cash-settled share of the number is unknown.
Inventory Divergence: Operating cash flow mainly reflected higher working capital with inventories deliberately built for ramps and China loading, against a +40% revenue print and claimed firm orders.

Friction Level: MODERATE_FRICTION — Both sides accept the beat. Disagreement is over whether full utilization is pricing power that expands margins or a hard cap on FY27 upside, and whether the undisclosed split between cash prepayments and contracted volume makes the guide earnings quality verifiable.

Report not found

The report data is no longer available. Please return to the archive.

Growth 40%, Every Plant Full, Cash Mix Withheld | Silicon Signal